Format
Sort by
Items per page

Send to

Choose Destination

See Gene information for diabetes insulin

Search results

Items: 1 to 20 of 50

1.

Lack of persistent remission following initial recovery in patients with type 1 diabetes treated with autologous peripheral blood stem cell transplantation.

Walicka M, Milczarczyk A, Snarski E, Jedynasty K, Halaburda K, Torosian T, Urbanowska E, Król M, Jędrzejczak WW, Franek E.

Diabetes Res Clin Pract. 2018 Sep;143:357-363. doi: 10.1016/j.diabres.2018.07.020. Epub 2018 Jul 21.

PMID:
30036612
2.

Variceal Hemorrhage and Adverse Liver Outcomes in Patients With Cystic Fibrosis Cirrhosis.

Ye W, Narkewicz MR, Leung DH, Karnsakul W, Murray KF, Alonso EM, Magee JC, Schwarzenberg SJ, Weymann A, Molleston JP; CFLDnet research group.

J Pediatr Gastroenterol Nutr. 2018 Jan;66(1):122-127. doi: 10.1097/MPG.0000000000001728.

PMID:
28906321
3.

Airway Glucose Homeostasis: A New Target in the Prevention and Treatment of Pulmonary Infection.

Baker EH, Baines DL.

Chest. 2018 Feb;153(2):507-514. doi: 10.1016/j.chest.2017.05.031. Epub 2017 Jun 10. Review.

PMID:
28610911
4.

Cystic fibrosis in Austria.

Frischer T, Eber E, Ellemunter H, Zacharasiewicz A, Kaluza I, Riedler J, Renner S.

Wien Klin Wochenschr. 2017 Aug;129(15-16):527-532. doi: 10.1007/s00508-017-1179-x. Epub 2017 Feb 24.

PMID:
28236043
5.

Heterogeneity in Survival in Adult Patients With Cystic Fibrosis With FEV1 < 30% of Predicted in the United States.

Ramos KJ, Quon BS, Heltshe SL, Mayer-Hamblett N, Lease ED, Aitken ML, Weiss NS, Goss CH.

Chest. 2017 Jun;151(6):1320-1328. doi: 10.1016/j.chest.2017.01.019. Epub 2017 Jan 20.

6.

Treatment Failure and Leg Amputation Among Patients With Foot Osteomyelitis.

Barshes NR, Mindru C, Ashong C, Rodriguez-Barradas M, Trautner BW.

Int J Low Extrem Wounds. 2016 Dec;15(4):303-312. doi: 10.1177/1534734616661058. Epub 2016 Sep 20.

PMID:
27581112
7.

Immunoablation and autologous hematopoietic stem cell transplantation in the treatment of new-onset type 1 diabetes mellitus: long-term observations.

Snarski E, Milczarczyk A, Hałaburda K, Torosian T, Paluszewska M, Urbanowska E, Król M, Boguradzki P, Jedynasty K, Franek E, Wiktor-Jedrzejczak W.

Bone Marrow Transplant. 2016 Mar;51(3):398-402. doi: 10.1038/bmt.2015.294. Epub 2015 Dec 7.

PMID:
26642342
8.

Gut microbe-derived extracellular vesicles induce insulin resistance, thereby impairing glucose metabolism in skeletal muscle.

Choi Y, Kwon Y, Kim DK, Jeon J, Jang SC, Wang T, Ban M, Kim MH, Jeon SG, Kim MS, Choi CS, Jee YK, Gho YS, Ryu SH, Kim YK.

Sci Rep. 2015 Oct 29;5:15878. doi: 10.1038/srep15878.

9.

Development of Gendine-Coated Cannula for Continuous Subcutaneous Insulin Infusion for Extended Use.

Jamal MA, Garoge K, Rosenblatt JS, Hachem RY, Raad II.

Antimicrob Agents Chemother. 2015 Aug;59(8):4397-402. doi: 10.1128/AAC.04956-14. Epub 2015 May 4.

10.
11.

Urinary tract infection and antibiotic sensitivity pattern among diabetics.

Simkhada R.

Nepal Med Coll J. 2013 Mar;15(1):1-4.

PMID:
24592783
12.

Combined heterotopic liver-pancreas transplantation as a curative treatment for liver cirrhosis and diabetes mellitus in cystic fibrosis.

Henn C, Kapellen T, Prenzel F, Siekmeyer M, Hau HM, Kiess W, Bartels M.

Pediatr Transplant. 2014 Feb;18(1):E6-9. doi: 10.1111/petr.12157. Epub 2013 Oct 18.

PMID:
24134590
13.

Insulin treatment modulates the host immune system to enhance Pseudomonas aeruginosa wound biofilms.

Watters C, Everett JA, Haley C, Clinton A, Rumbaugh KP.

Infect Immun. 2014 Jan;82(1):92-100. doi: 10.1128/IAI.00651-13. Epub 2013 Oct 14.

14.

Exocrine cell-derived microparticles in response to lipopolysaccharide promote endocrine dysfunction in cystic fibrosis.

Constantinescu AA, Gleizes C, Alhosin M, Yala E, Zobairi F, Leclercq A, Stoian G, Mitrea IL, Prévost G, Toti F, Kessler L.

J Cyst Fibros. 2014 Mar;13(2):219-26. doi: 10.1016/j.jcf.2013.08.012. Epub 2013 Oct 2.

15.

Pseudomonas aeruginosa biofilms perturb wound resolution and antibiotic tolerance in diabetic mice.

Watters C, DeLeon K, Trivedi U, Griswold JA, Lyte M, Hampel KJ, Wargo MJ, Rumbaugh KP.

Med Microbiol Immunol. 2013 Apr;202(2):131-41. doi: 10.1007/s00430-012-0277-7. Epub 2012 Sep 25.

16.

Antidiabetic, anti-oxidant and antimicrobial activities of Fadogia ancylantha extracts from Malawi.

Nyirenda KK, Saka JD, Naidoo D, Maharaj VJ, Muller CJ.

J Ethnopharmacol. 2012 Aug 30;143(1):372-6. doi: 10.1016/j.jep.2012.07.002. Epub 2012 Jul 16.

PMID:
22800680
17.

[Epidemiology and clinical features in diabetic patients with invasive infections treated at the Clinical Hospital of Infectious Diseases of Iaşi, Romania, between 2008-2010].

Petrovici CG, Dorobăt C, Bejan C, Juganariu G, Simiraş E, Filip O, Luca V, Miftode E.

Rev Med Chir Soc Med Nat Iasi. 2011 Oct-Dec;115(4):1035-41. Romanian.

PMID:
22276442
18.
19.

Use of granulated sugar therapy in the management of sloughy or necrotic wounds: a pilot study.

Murandu M, Webber MA, Simms MH, Dealey C.

J Wound Care. 2011 May;20(5):206, 208, 210 passim.

PMID:
21647066
20.

alpha-Glucosidase inhibitory activities of 10-hydroxy-8(E)-octadecenoic acid: an intermediate of bioconversion of oleic acid to 7,10-dihydroxy-8(E)-octadecenoic acid.

Paul S, Hou CT, Kang SC.

N Biotechnol. 2010 Sep 30;27(4):419-23. doi: 10.1016/j.nbt.2010.04.002. Epub 2010 Apr 10.

PMID:
20385262

Supplemental Content

Loading ...
Support Center